{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:17:58Z","timestamp":1747156678988,"version":"3.40.5"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.canep.2024.102660","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T22:10:46Z","timestamp":1726006246000},"page":"102660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Trends in the incidence and mortality of cervical, ovarian, and corpus uteri cancers in Wales, UK: A joinpoint regression analysis from 2002 to 2021"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9788-2028","authenticated-orcid":false,"given":"Sindhu","family":"Sekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srividhya","family":"Budithi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujeewa","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2024.102660_bib1","unstructured":"Ferlay J., Ervik M., Lam F., Colombet M., Mery L., Pi\u00f1eros M., Znaor A., Soerjomataram I., Bray F. (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. [cited 2024 August 13]. Available from: http:\/\/gco.iarc.fr\/today\/home."},{"issue":"1","key":"10.1016\/j.canep.2024.102660_bib10","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA: A Cancer J. Clin. [Internet]"},{"issue":"11","key":"10.1016\/j.canep.2024.102660_bib11","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","article-title":"Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study","volume":"20","author":"Arnold","year":"2019","journal-title":"Lancet Oncol."},{"issue":"10316","key":"10.1016\/j.canep.2024.102660_bib15","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.canep.2024.102660_bib16","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/S2468-2667(17)30222-0","article-title":"Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study","volume":"3","author":"Castanon","year":"2018","journal-title":"Lancet Public Health"},{"issue":"10290","key":"10.1016\/j.canep.2024.102660_bib18","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.canep.2024.102660_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am. J. Hum. Genet"},{"issue":"2","key":"10.1016\/j.canep.2024.102660_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.canep.2024.102660_bib21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/tbj.12978","article-title":"Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK","volume":"24","author":"Long","year":"2018","journal-title":"Breast J."},{"issue":"2","key":"10.1016\/j.canep.2024.102660_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cncr.22371","article-title":"Development of an ovarian cancer symptom index: possibilities for earlier detection","volume":"109","author":"Goff","year":"2007","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.canep.2024.102660_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2007.12.022","article-title":"Combination prophylaxis for thromboembolism prevention among gynecologic oncology patients perioperatively","volume":"109","author":"Martino","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canep.2024.102660_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejogrb.2021.11.423","article-title":"British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: recommendations for practice","volume":"270","author":"Morrison","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol. [Internet]"},{"issue":"12","key":"10.1016\/j.canep.2024.102660_bib28","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/1055-9965.EPI-10-0832","article-title":"Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis","volume":"19","author":"Crosbie","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"6","key":"10.1016\/j.canep.2024.102660_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners\u2019 Oral Contraception Study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.canep.2024.102660_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/2053369117709225","article-title":"Obesity and ovarian cancer risk: a systematic review","volume":"23","author":"Foong","year":"2017","journal-title":"Post Reprod. Health"},{"issue":"7","key":"10.1016\/j.canep.2024.102660_bib35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/1471-0528.12106","article-title":"Obesity-driven endometrial cancer: is weight loss the answer?","volume":"120","author":"MacKintosh","year":"2013","journal-title":"BJOG: Int. J. Obstet. Gynaecol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782124001395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782124001395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T11:30:33Z","timestamp":1732620633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782124001395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":16,"alternative-id":["S1877782124001395"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2024.102660","relation":{},"ISSN":["1877-7821"],"issn-type":[{"type":"print","value":"1877-7821"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in the incidence and mortality of cervical, ovarian, and corpus uteri cancers in Wales, UK: A joinpoint regression analysis from 2002 to 2021","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2024.102660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102660"}}